Please ensure Javascript is enabled for purposes of website accessibility

UM Ventures program finds success with Living Pharma acquisition (access required)

Lentigen acquired University of Maryland, Baltimore startup Living Pharma last week just 18 months after the company was founded, an initial success for a university program designed to turn languishing technologies into successful companies. The New Ventures Initiative, run out of the school’s tech transfer office, has focused on finding technology that probably would have remained ...

To purchase a reprint of this article, contact [email protected].